Gaudium IVF and Women Health Ltd
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
- Market Cap ₹ 778 Cr.
- Current Price ₹ 107
- High / Low ₹ 164 / 69.2
- Stock P/E 33.6
- Book Value ₹ 20.9
- Dividend Yield 0.00 %
- ROCE 29.3 %
- ROE 24.7 %
- Face Value ₹ 5.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty IPO BSE Healthcare BSE IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 37 | 44 | 48 | 71 | 104 | 106 | |
| 23 | 24 | 28 | 42 | 67 | 71 | |
| Operating Profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37% | 46% | 41% | 41% | 36% | 33% |
| 0 | 0 | 0 | 0 | 0 | 2 | |
| Interest | 1 | 0 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 | 2 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 | 31 |
| Tax % | 26% | 26% | 38% | 25% | 24% | |
| 9 | 14 | 10 | 19 | 24 | 23 | |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 | 3.51 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 33% |
| TTM: | 48% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 22% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 34% |
| Last Year: | 25% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| 6 | 12 | 17 | 21 | 25 | |
| 3 | 2 | 7 | 22 | 16 | |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| 4 | 18 | 19 | 18 | 30 | |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| 14 | 18 | 32 | 58 | 158 | |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -1 | 24 | 3 | 9 | 7 | |
| -1 | -16 | -5 | -15 | -88 | |
| 3 | 5 | -1 | 2 | 82 | |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | -0 | 5 |
| CFO/OP | 13% | 141% | 27% | 46% | 51% |
Ratios
Consolidated / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | 76% | 45% | 49% | 29% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Average Revenue Per Patient (ARPP) INR Lakhs |
|
|||
| IVF Success Rate (First Attempt) % |
||||
| IVF Treatment Revenue Share % |
||||
| Number of Embryologists count |
||||
| Number of OPU (Ovum Pick-Ups) count |
||||
| International Patients Share % |
||||
| Number of Hubs count |
||||
| Number of Spokes count |
||||
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 11th AGM resolutions approved; voting results and scrutinizer report filed on September 29, 2026.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Gaudium IVF held its 11th AGM on September 28, 2026; all resolutions were transacted, voting results pending.
- Closure of Trading Window
-
Intimation Under Regulation 30 And Para B, Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At Gurgaon, Haryana
- Gurgaon IVF centre/hub began operations on September 24, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026PPT
-
May 2026Transcript PPT REC
Business Profile[1][2]
The company operates in the Assisted Reproductive Technology (ART) and IVF segment in India, following a hub-and-spoke model across 30+ locations (7 hubs and 28 spokes). It also runs a 15-bed day-care hospital in Janakpuri (Delhi NCR) and operates an in-house pharmacy through its wholly owned subsidiary, Gaudium International Pvt. Ltd.